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Evaluation of Needle Exchange Programs
Cheryl Delgado, M.S.N., R.N.
Abstract Needle exchange programs exist in every major popu-
lation area in the United States and in many other countries.
Some operate legally under emergency health decrees issued by
local departments of health, with the stated intention of risk
reduction through the removal of used injection equipment
from use by injection drug users. It is theorized that this results
in a reduced transmission of human immunodeficiency virus,
hepatitis, and, possibly, other blood-borne diseases. Needle
exchange programs also offer access to drug treatment programs
for the participants. It is a difficult but necessary task to evaluate
these programs. This article examines examples of evaluations
attempted in the past and discusses the challenges of such evalu-
ations. Experimental evaluations, economic program analysis,
legal aspects, and risk–benefit assessment along with ethical
aspects are considered. An outline of program evaluation is
proposed. Needle exchange programs offer an opportunity to
encourage risk reduction and to offer counseling and access to
health care for individuals at high risk. It is essential that such
programs demonstrate their effectiveness. Assumptions of effi-
cacy are insufficient for health care in the twenty-first century.
Key words: needle exchange, programevaluation,AIDS, hepatitis.
Needle exchange programs (NEPs) are not uncommon in
urban America. Programs exchange used syringes for
unused syringes in intravenous drug users to prevent the
reuse of contaminated injection equipment. Other materials
may be provided by NEPs, including bleach bottles,
cotton swabs, skin ointment, condoms, and educational
handouts about human immunodeficiency virus (HIV)/
acquired immunodeficiency syndrome (AIDS), sexually
transmitted infections, and other communicable illnesses.
The purpose of the exchange and supply of such items
is to reduce the risk of transmission of communicable
disease by the intravenous drug user. Most NEPs com-
bine a program goal of risk reduction through needle
exchange with a program goal of offering counseling
and referral of participants to drug treatment programs.
NEPs commonly operate under local department of
health emergency orders. Chief officials of local health
districts are charged with public safety. They have
authority to issue orders for the protection of the public
health through the prevention of disease or restriction of
the spread of disease. Orders from such officials author-
izing the legal operation of the NEP are a response to the
epidemic of HIV infection among injection drug users
(IDUs). Authorization orders that are issued under a
state public health code typically follow this format:
Step 1, a health emergency is declared; Step 2, the local
spread of HIV through drug use is described; Step 3,
evidence of NEPs as an effective preventative measure is
provided; Step 4, the emergency is periodically redeclared
for the continued operation of the program (Burris,
Finucane, Gallagher, & Grace, 1996). This conditional
and emergency nature of the authorization will often
be stated in the general description of the program for
the political authorities that provide legal cover for the
activity of the exchange program. Programs emphasize the
protective nature of the exchange for the public at large.
Rules and regulations for the NEP usually mandate the
existence of a demonstrable infrastructure and a phys-
ician director who is readily available in the local area.
Participants are commonly limited to adults 18 years and
older, with identification cards for proof of participation.
Program staff is also usually identified. Other regulations
are to ensure participant confidentiality and staff and
participant safety, training regarding blood-borne patho-
gens and CPR, and the capability of the staff to provide
one-on-one education for HIV and risk-reduction behaviors.
Exchange sites are generally not allowed close to schools,
churches, playgrounds, and day care or recreation centers,
and programs must maintain a regular schedule with iden-
tified sites for the exchanges. An NEP which operates as a
medical facility must provide HIV testing, counseling for
risk reduction, referral for other medical and social services,
and substance abuse assessments with links to drug treat-
ment facilities. In addition, liability insurance is often
required.
DISCUSSION OF LEGAL ASPECTS
Legal issues for NEPs center on drug paraphernalia.
Possession and delivery of drug paraphernalia is illegal
in 46 states and the District of Columbia (Burris et al.,
1996). Most of these laws are based on a model from the
United States Drug Enforcement Agency written in 1979
that criminalized the manufacture, possession, and dis-
tribution of drug paraphernalia. Drug paraphernalia is
loosely defined to include any equipment, product, or
material intended to be used to introduce an illicit sub-
stance into the body. Intent is an important aspect of this
law, as it transforms ordinary items like bleach, cotton
balls, and paper clips from household items into drug
paraphernalia. Materials supplied by programs are para-
phernalia, and therefore, trafficking in them could be
illegal. Some states require a prescription for syringes,
and possession of them without prescription is a criminal
offense (Webber, 1997).
According to Burris et al. (1996), current programs for
syringe or needle exchange fall into two broad categories:
illegal and legal. The illegal programs operate without
legal basis, and participants are subject to prosecution.
Legal programs operate in areas where there is no local
drug law, or by indirect authorization through amend-
ment or judicial interpretation of drug laws. Direct
authorization allows NEPs in Cleveland, Philadelphia,
Los Angeles, San Francisco, and six other areas in
California to claim legality based on local interpretation
of state public health or drug laws. Courts generally defer
to public health officials and rarely overturn necessary
actions taken to prevent the transmission of disease.
Examples include mandatory vaccinations, testing for
some sexually transmitted diseases, prophylactic eye
treatments for newborns, and even fluoridation of water
supplies. All states have laws that require and empower
public health officials to protect the public (Burris et al.,
1996). Programs with no or shaky legal support operate
because of the tolerance of law enforcement and political
leaders. They may tacitly support NEPs, although not be
willing to act openly. Also, NEPs may not be considered
an important enough activity to merit police attention.
Law enforcement agencies are more interested in appre-
hending dealers than identifying users.
ETHICAL ISSUES AS A RISK–BENEFIT
EVALUATION
According to Loue, Lurie, and Lloyd (1995), an ethical
assessment requires consideration of four elements:
beneficence versus maleficence, respect of persons (auton-
omy, dignity, and confidentiality), justice and fairness,
and utilitarianism. Few drug treatment programs have
long-term success, and many drug users do not seek
treatment. The principle of risk reduction accepts that a
dangerous behavior like intravenous drug use is inevit-
able. Health officials therefore have a responsibility to the
general public to reduce risks associated with the acts
(drug use) they cannot prevent. Risk reduction is a more
reasonable goal than attempts to eradicate illegal intra-
venous drug use. NEPs benefit participants by reducing
the risk of disease (HIV/AIDS and hepatitis) in IDUs by
providing clean injection equipment. Risks of HIV/AIDS
and associated diseases are reduced in the sex partners
and children born of the IDU as well. NEPs may be used
to access counseling, testing, and treatment services, and
dirty injection equipment is collected rather than haphaz-
ardly discarded in the community. Some studies have
concluded that an NEP that is easily accessed by the
IDU will replace black-market sources (Watters, Estilo,
Clark, & Lorvick, 1994). There is then reduced risk
not only to the intravenous drug user but also to other
members of the immediate community and to society in
general, in terms of the potential limitation of the spread
of communicable disease, specifically hepatitis, tuber-
culosis, and HIV.
Those opposed to NEPs argue that it is harmful
(maleficent) to provide injection equipment as it con-
dones and may encourage intravenous drug use that is
an illegal, self-destructive act. Many feel that the time,
money, and energy expended in NEPs would be better
spent on treatment programs that are chronically under-
funded. Others, who do not receive free clean needles but
require them for the treatment of chronic illnesses such as
diabetes, ask whether it is a justifiable or fair allocation of
limited resources.
For an NEP to be useful to the public (utilitarianism)
and satisfy the purpose of the emergency order, local con-
ditions must be taken into consideration. Neighbors to an
exchange site may feel a disproportionate impact from the
NEP in their area. Drug traffic may increase in the area of
the exchange site. No studies have addressed this particular
question, although studies have concluded that crime rates,
in general, are not affected by the operation of an NEP
(Marx et al., 2000). Loue et al. (1995) wrote that ‘‘even for
drug users who continue to inject, rates for drug related
crimes will be somewhat reduced due to IDU’s decreased
need for the funds to purchase or lease paraphernalia to
inject drugs’’ (p. 383). This is an optimistic statement con-
sidering that the main expense of the IDU is the drug and
not the equipment. A study by Watters et al. (1994) was
able to conclude only that the availability of clean injection
equipment reduced needle sharing and associated disease
but did not impact on drug use itself. A more recent study
has indicated that needle exchange alone may not be
enough to reduce risks of disease spread by blood-borne
viruses. Other equipments involved in the preparation and
dividing of drugs may be sources of contamination (Hagan
& Theide, 2000). Discards of contaminated needles may be
decreased (beneficence) in the local area, according to one
study (Loue et al., 1995), or are at least not increased,
according to Doherty et al. (2000). A major community
concern is redistribution of needles provided by the NEP.
The question of local neighborhood autonomy also
arises. Harlan Dalton, quoted from ‘‘AIDS in Blackface,’’
Daedalus 1989 in Stryker and Smith (1993) is eloquent.
‘‘For us (African-Americans) drug use is a curse far
worse than you can imagine. Addicts prey on our
neighborhoods, sell drugs to our children, steal our
possessions, and rob us of hope. We despise them.
. . .Why can’t we choose which of the many problems
facing us to tackle first? Suppose we think that crack is
more of a menace than AIDS. Are you willing to help
us take that one on? Why do you want us to take all
the risks?
PROGRAM EVALUATION CHALLENGES
The evaluation of controversial programs such as an NEP is
a challenge but essential for politicians and granting agencies
who need a sound basis for decisions, not only for funding
and grant appropriations but also for the legal manipula-
tions necessary for continued operation. Within the NEP,
management decisions regarding budget allocation and
resource utilization must be made. A program evaluation
answers the question ‘‘What is the effect of the program?’’
The scope of a programmay be a problem for evaluators.
The geographic area may be large and poorly defined or
even impossible to define. Do the effects of a program stop
at the city or county lines? If the program evaluates in terms
of population rather than geographic area, what is that
population? Who is included, excluded, and why? The
quality of the program goals will have a significant effect
on the evaluation. Are the goals clear and precisely stated?
Are they measurable? Goals that are vague or global
in nature may require a discussion of the concepts
involved, so that the evaluators and the program actors
are in agreement.
The politics of an evaluation must also be considered.
Varied stakeholders have different interests in the program
and may have an influence on the evaluation, even inadvert-
ently. The concerns of all stakeholders should be included in
planning evaluations, so that all concerns are addressed and
none is disproportionately represented. In any evaluation
scheme, the clarity and specification of the program goals
in the planning and pre-implementation stage is important.
Mateo and Kirchoff (1999) see program evaluations as
formative or summative. Formative evaluations assess,
report, and monitor the implementation and progress of
a program. A well-defined purpose for the program, reali-
stic goals, and measurable variables of interest are
needed. Formative evaluations may also look at specifics
of the program operation, such as staff training. Summa-
tive evaluations assess the effectiveness of the program
after the desired change has been implemented. The ques-
tions answered by a summative evaluation included
whether or not the goals of the program were accom-
plished, whether the purpose of the program was upheld,
and whether there were any unanticipated results from
the program change. A summative evaluation could com-
pare the program results with other similar interventions.
Experimental evaluative designs are expensive and diffi-
cult to design in terms of control group and random
assignments. They may also be unethical if they do not use
or if they exclude the use of other related pre-existing
programs. Experimental designs tend to be artificial in the
degree of control in a setting and may not provide insight
into the real world where a program operates. It may be
impossible to understand and isolate the effects of all pos-
sible influence variables in a community setting. Evaluations
may use experimental, quasi-experimental, cross-sequential,
and descriptive methods. Both qualitative and quantitative
methods of data collection are useful. Brink and Woods
(1998) assume the following in any evaluative design:
1 measurable objectives for the program that can be
used as a basis for evaluation;
2 methods or tools available to measure the variables;
3 objectives prioritized according to their value to the
program;
4 control participants in adequate numbers for statis-
tical tests to be significant.
EXAMPLES OF NEEDLE PROGRAM
EVALUATIONS
The overall intention of NEPs and the justification for
the legal machinations necessary to operate exchange
programs in the United States is the protection of the
general public against the spread of blood-borne viral
disease, specifically HIV and hepatitis. A secondary goal
is the contribution to the control of other infectious
diseases, such as tuberculosis. A pure experimental
evaluation of that relationship is impossible, but quasi-
experimental studies have been performed, with con-
flicting results. Bruneau et al. (1997) found an increase
in HIV rates among participants in the programs evalu-
ated, but this was not the case for Hurley, Jolley, and
Kaldor (1997), who found a decrease in HIV serocon-
version among participants in their study. No one has
made the attempt to relate the program under study to
HIV incidence in the general population rather than the
direct program participants, even though such a benefit is
often a stated goal. This makes the inclusion of such a goal
suspect as a political maneuver rather than a true aim of
the program. It is no doubt successful as an instrument
in obtaining initial approval for an exchange program
(what politician would stand against a program purported
to prevent the spread of a dread disease to innocent
voters), but it is unmanageable as an outcome measure
and could backfire if program opponents take the position
that reduction of infection rates in the general population
is a criteria for continued support of the program.
Cohort studies have been used in NEP evaluations.
Experimental studies for program evaluation are difficult
to design. Obtaining informed consent of the participants
would be a challenge, and the potential for bias would be
considerable. Both Bastos and Strathdee (2000) and
Hagan et al. (2000b) indicate that selection factors often
lead to over-representation of high-risk drug users in
NEPs. Although Des Jarlais, Dehne, and Casabona
(2001) state that it will probably never be possible to
obtain a true random sample from an IDU population,
they believe that it is possible to locate and conduct
research with IDUs. They suggest that research studies
for monitoring the prevalence of a disease (surveillance
studies) should include assessment of risk behaviors,
because reports of infection rates alone may not be suf-
ficiently time sensitive. This seems especially true in dis-
eases such as AIDS, where a decade or more may ensue
between infection and the onset of active disease. The
primary risk behaviors of the target group to be measured
would be the sharing of drug injection equipment, the
potential for rapid turnover of partners, and the incidence
of high-risk sexual practices, as well as other demo-
graphics such as the size of the target population, their
patterns of drug use, and their participation in prevention
activities and access to treatment programs. The design
was strong in that it combines both formative and
summative measurements.
The ideal experimental evaluation would be a longitu-
dinal study that followed up a cohort of IDUs for an
extended period of time after baselines measurements
were established for these behaviors and compared them
with equivalent control group of IDUs who did not par-
ticipate in the program. In reality, such a plan would be
impossible to implement, not only because of the expense
or ethical concerns involved (which alone are colossal),
but because it would be impossible to insulate the study
from cultural, economic, and societal changes, in general,
that would confound the data. This was demonstrated in
a longitudinal study (Van Ameijden & Coutinho, 2001)
conducted in The Netherlands with an open cohort study
from 1986 to 1998, using a total of 996 drug users
recruited during that time and 4-month follow-ups.
Generalized estimating equations used for statistical
analysis revealed a decrease in injected drug use but
noted an increase in noninjected drug use. Mortality and
migration explained one-third of the decrease in injection
drug use, and the study concluded that the decrease in
injection drug use was not related to the large-scale needle
program but to ecologic factors of the drug culture
and market. During that historical period, cocaine, not
injectable drugs, became popular among users.
The demographics of NEP participants were profiled
by Belanger et al. (2000). This may be useful to planners
of programs and in the evaluation of whether or not the
target population had been affected by the program.
A cohort study in Seattle (Hagan et al., 2000a) was
carried out for a 12-month period, examining the rela-
tionship between needle exchange and enrolment and
retention in methadone drug treatment. Participant
entry to drug treatment programs is often a stated goal
of NEPs and could be an outcome variable for summative
evaluation. This study did find that new users of the
program were five times more likely to enter drug treat-
ment, and the assumption was made that drug use
was reduced and that the public, thereby, benefited
from the prevention of blood-borne viral disease trans-
mission, although this was not specifically addressed in
the study.
Most often, program goals are global, idealistic, and
difficult to measure. A more practical approach is the
formative evaluation that examines the process of imple-
mentation and operation of the program. The evaluator
may look at steps taken to reduce the risk of the spread of
infection rather than the prevalence of the disease itself in
a community. Disease rates may have many contributing
factors, and it may not be possible to isolate the impact of
a particular program. A program that looks at changes in
constituent behaviors related to a disease may find them
more measurable. For NEPs, this is often a determination
of the program’s impact on needle-sharing behavior
among participants.
Marmour, Shore, Titus, Chen, and Des Jarlais (2000)
found a decreased acceleration of injection habits
among participants in an NEP in New York City. Other
behaviors of IDUs such as sharing or reuse of injection
equipment were examined by several researchers includ-
ing Heimer, Khoshnood, Bigg, Guydish, and Junge
(1998), Guydish, Bucardo, Clark, and Bernheim (1998),
and Blumenthal, Kral, Gee, Erringer, and Edlin (2000).
Risk reduction by this mechanism is often a stated goal of
NEPs. All researchers found that this behavior was
reduced in program participants. One study (Broadhead,
van Hulst, & Hecksthorn, 1999) found that the closing of
an NEP resulted in an increase in the incidence of high-
risk sharing behaviors by former participants.
PROGRAM ANALYSIS—ECONOMIC ASPECTS
Politics, in general, have had an impact on the evaluation
of NEPs in the United States. Because no federal funds
have been available for studies, most information about
the effectiveness of programs has come from Europe and
Canada. This financial bias existed both in the recent
Democratic administration and in the current Republican-
controlled Congress. It is not likely to change at the
federal level.
NEPs receive operating funds from four general
sources: local governments, foundation grants, private
donation, and activist or community organizations that
run NEPs. Most programs require more than one source.
Federal law prohibits funding of NEPs (Webber, 1997),
and local officials who tacitly accept what they see as the
necessary evil of needle exchange are seldom willing to
provide much sought after public money. Still, of 13 legal
programs surveyed by Lurie and Chen (1993), only one
was without direct or indirect government funds.
More substantial funding comes from foundation
grants—on a national level, the American Foundation
for AIDS Research (AmFAR) and the Robert Wood
Johnson Foundation. AmFAR has also been used to
distribute government funds. Often, grant money from
foundations is seed money for the purpose of initial
setup or demonstration. Donations from private persons,
through fund-raisers (solicitation, dinners, and concerts),
are a major source of money but only in the United
States. Programs relying on money from local donation
or activist support are less likely to be legally based (Lurie
& Chen, 1993).
General operating budgets are made up of corporate
donations, foundation grants, individual donations,
and funds from special events. Limited funds must be
spent in the most cost-effective way, and controversial
programs will need to justify costs to sponsors. Some
donations may be lost because of the NEP, and the
effects of this would have to be factored into any cost–
benefit analysis. Reid (2000) advocates the use of cost–
benefit analysis for evaluations of NEPs, yet this is
difficult to do when the needle exchange produces no
revenue or easily measurable benefit to balance with
costs.
The real economics of an NEP are difficult to calculate.
What value can be assigned to prevention? How does one
accurately measure the number of people who do not get
AIDS from contaminated needle use? We can estimate
the number of IDUs in a target population and relate this
to estimates that the HIV infection rate of IDUs is
approximately 50%, with additional infections in their
sex partners and children (Loue et al., 1995). The costs
of drug treatment, medical care, supportive social pro-
grams, and other nondirect costs can be calculated. These
calculations do not include associated diseases such as
tuberculosis or hepatitis, but that could be done. A
study by Pearlman et al. (2001) examined the costs of
tuberculosis screening associated with an NEP in New
York City and found that net savings made the program
cost-effective, as compared with treating active cases of
tuberculosis.
In Canada, Jacobs et al. (1999) calculated that the
value of a 1-year delay in HIV infection was worth
$9,500 per case. Another Canadian study conducted by
Gold, Gafni, Nelligan, and Millso (1997) estimated that
the HIV incidence rate would be decreased from 4 to 2%
by the program and that with 275 participants, 24 cases of
HIV would be prevented over a 5-year period. Estimating
the lifetime costs of health care for AIDS patients, but
omitting the indirect costs associated with lost productiv-
ity and costs incurred by informal caregivers, it was a
conservative prediction that the program studied would
provide a cost saving of $1,300,000 (Canadian dollars)
after accounting for program costs.
Just as the opening and operation of an NEP in a
community should be carefully negotiated with the resi-
dents of the area, local politicians and other leaders,
evaluation of the program needs to be done with par-
ticipation of these stakeholders. Even well-supported
scientific evidence will not stand against community per-
ceptions of risks and benefits. Focus groups comprised of
clergymen, educators, local health care providers, and
interested area citizens would provide important informa-
tion about impact of the program on the community.
Health care facilities and educational institutions in the
area should co-ordinate services and facilities and tailor
programs for specific local needs.
A PROPOSAL FOR PROGRAM EVALUATIONS
Monitoring the prevalence of HIV and hepatitis infection
in IDUs should be done, even though this is not likely to
provide support for the program. Because disease rates
have been used as justification for many programs, a
significant change in disease rates, from any cause,
would mandate reexamination of the program goals and
purpose.
On an operational level, the following steps could be
valuable.
1 Initial steps of the evaluation:
. The program must document compliance with all
rules and regulations of the authorization order.
. Surveys should be regularly carried out to monitor
the training status and activities of the program staff
to ensure that they are following the process outlined
by the program (record keeping, utilization of nego-
tiated sites, etc.). A log of problems needing atten-
tion could be established and discussed at regularly
scheduled staff meetings. Staff should also be
encouraged to share ideas regarding ways to improve
the program.
. Records should be reviewed to determine program
usage by participants.
2 Measuring the variables of interest:
. Workers who have established some relationship
with program participants could be trained to collect
qualitative (interview) data regarding drug-use
trends, needle- and equipment-sharing activity, and
lifestyle, including high-risk sexual behaviors of the
participants. Process variables such as number of
participants, number of return participants, number
of participants entering drug treatment, and number
of participants utilizing other health services (med-
ical care and psychological counseling) should be
tracked on an ongoing basis.
. Focus groups comprised of community leaders
should be utilized to monitor the community image
of the program and identify any unanticipated
effects of the program.
3 Data collection and analysis:
. Narrative accounts of program implementation and
function from staff meeting minutes will give an
account of how well the program is being run. Nar-
rative data will need analysis for explication of recur-
rent or meaningful observations and problems. In
this manner, a qualitative process evaluation can be
made.
. Quantitative and qualitative data regarding the
usage of services should be collected without
disruption of services. Quantitative data would
document current service usage. Qualitative data
would give insight into how current services are
received by drug users and provide some anecdotal
support for effectiveness. Information should be col-
lected in a systematic and uniform manner, so that
appropriate statistical analyses may be made with
confidence. Information should be coded to preserve
anonymity of participants.
4 Evaluating data analysis:
. Evaluations should be carried out by uninterested
parties rather than by stakeholders to eliminate bias.
. Cost–benefit analysis should be attempted despite
inherent challenges, using best-guess estimates
(clearly identified as such) when necessary.
Program evaluations can be difficult and time consum-
ing. Often, program goals change or evolve during the
course of a program or are ambiguously stated. Planning
how program evaluation will be carried out should occur
early in the development of a program and should focus
on the issues important to the administrators of the NEP.
Without knowledge of the focus of a program, it is pos-
sible that an evaluation may miss unanticipated effects
of the program that might be beneficial. In a goal-free
evaluation, there is an examination of the overall effect of
the program, rather than an evaluation based on a priori
goals. All evaluation programs must be formulated to
match the program to be evaluated. There is no one
right method or design. A good overview of evaluative
research designs is provided by Portney and Watkins
(2000) in their text Foundations of Clinical Research.
Another good resource for those planning a program
evaluation for an NEP would be Mateo and Kirchoff’s
(1999) Using and Conducting Nursing Research in the
Clinical Setting.
CONCLUSIONS
More outcome research is needed on NEPs, but there are
many challenges. Academic institutions may not be sup-
portive of this type of research because of the controver-
sial nature of the programs. Institutional review boards
may not approve projects involving acts of questionable
legality. Funding for research could be scarce for the
same reason. Research in this area may not be considered
scholarly or worthy of investigation, and design of
research studies would be a challenge. NEP participants
are self-selected, making randomization, bias, and control
major concerns.
The National Academy of Sciences, the National
Commission on AIDS, the General Accounting Office
of the United States, and the University of California
under the sponsorship of the Center for Disease Control
have attested to NEP efficacy. Center for Disease Control
concludes that NEPs are ‘‘likely to reduce HIV trans-
mission’’ and ‘‘no evidence of any NEP related increases
in community levels of drug use’’ (anon., in Loue et al.,
1995). The growing number of NEPs indicates increased
acceptance. As an opportunity to encourage risk reduc-
tion and to offer counseling and access to health care for
individuals at high risk, NEPs should not be overlooked.
Yet, the emphasis on cost-effective interactions makes it
essential that these programs be able to demonstrate their
effectiveness with proven outcome evaluations. Assump-
tions of efficacy are insufficient for providers and users of
health care services in the twenty-first century.
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